Giuseppe Di Tano Selected Research

Giuseppe Di Tano Research Topics

Disease

25	Heart Failure 05/2022 - 12/2002
12	COVID-19 01/2023 - 01/2020
5	Pneumonia (Pneumonitis) 04/2022 - 01/2020
5	Inflammation (Inflammations) 04/2022 - 09/2016
4	Atrial Fibrillation 01/2018 - 03/2016
3	Acute Coronary Syndrome 10/2019 - 08/2010
3	Left Ventricular Dysfunction 01/2019 - 09/2007
3	ST Elevation Myocardial Infarction 01/2019 - 01/2017
2	Pulmonary Embolism 04/2022 - 01/2020
2	Cardiotoxicity 04/2022 - 10/2012
2	Heart Diseases (Heart Disease) 11/2021 - 01/2018
2	Sudden Death 12/2020 - 11/2015
2	Myocardial Infarction 11/2020 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2018 - 09/2007
2	Anterior Wall Myocardial Infarction 01/2018 - 01/2017
2	Fibrosis (Cirrhosis) 05/2017 - 09/2016
2	Cardio-Renal Syndrome 05/2017 - 09/2016
1	Myocarditis (Carditis) 01/2023
1	Neoplasms (Cancer) 04/2022
1	Mitral Valve Insufficiency (Mitral Regurgitation) 11/2021
1	Systolic Heart Failure 10/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Thrombosis (Thrombus) 07/2020
1	Infections 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Heart Valve Diseases (Valvular Heart Disease) 03/2019
1	Infarction (Infarctions) 01/2019
1	Cicatrix (Scar) 01/2019
1	Edema (Dropsy) 11/2018
1	Shock 11/2018
1	Fever (Fevers) 04/2018
1	Chest Pain (Chest Pains) 04/2018
1	Pericardial Effusion 04/2018
1	Cardiac Tamponade 04/2018
1	Ventricular Remodeling 01/2018
1	Stroke (Strokes) 05/2017
1	Diabetes Mellitus 11/2012
1	Breast Neoplasms (Breast Cancer) 10/2012

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 11/2021 - 05/2010
7	sacubitril and valsartan sodium hydrate drug combinationIBA 04/2022 - 01/2017
4	AnticoagulantsIBA 04/2022 - 09/2016
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 11/2020
4	Natriuretic PeptidesIBA 02/2017 - 05/2010
3	Neprilysin (Neutral Endopeptidase)IBA 10/2021 - 02/2017
3	Enalapril FDA LinkGeneric 10/2021 - 10/2018
3	GadoliniumIBA 01/2019 - 11/2015
3	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2017 - 09/2007
2	CreatinineIBA 11/2021 - 11/2012
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2021 - 10/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2021 - 12/2002
2	Angiotensin Receptor AntagonistsIBA 10/2021 - 02/2017
2	Ritonavir (Norvir)FDA Link 01/2021 - 01/2021
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 01/2020
2	C-Reactive ProteinIBA 01/2021 - 10/2020
2	TroponinIBA 11/2018 - 05/2010
2	Galectin 3 (LGALS3)IBA 01/2018 - 01/2017
2	pro-brain natriuretic peptide (1-76)IBA 01/2018 - 02/2017
2	DiureticsIBA 04/2010 - 09/2007
1	Messenger RNA (mRNA)IBA 01/2023
1	fibrin fragment D (D-dimer)IBA 04/2022
1	Fibrinogen (Factor I)FDA Link 04/2022
1	Antineoplastic Agents (Antineoplastics)IBA 04/2022
1	Hemoglobins (Hemoglobin)IBA 11/2021
1	Untranslated RNA (Noncoding RNA)IBA 11/2021
1	Long Noncoding RNAIBA 11/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	SodiumIBA 10/2021
1	Mineralocorticoid Receptor AntagonistsIBA 10/2021
1	SymportersIBA 10/2021
1	cobicistat mixture with darunavirIBA 01/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2021
1	Darunavir (Prezista)FDA Link 01/2021
1	Lopinavir FDA Link 01/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2021
1	Vitamin K FDA Link 01/2020
1	RivaroxabanIBA 01/2020
1	cangrelorIBA 10/2019
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Amiodarone (Amiodarona)FDA LinkGeneric 03/2016
1	Troponin T (Troponin T1)IBA 11/2012
1	Taxoids (Taxanes)IBA 10/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2012

Therapy/Procedure

17	Therapeutics 05/2022 - 09/2007
5	Percutaneous Coronary Intervention 11/2020 - 01/2017
3	Length of Stay 10/2015 - 12/2003
2	Heart Transplantation (Grafting, Heart) 05/2022 - 11/2018
2	Aftercare (After-Treatment) 10/2021 - 08/2021
2	Ambulatory Care (Outpatient Care) 05/2019 - 07/2016
1	Heart-Assist Devices 05/2022
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2020
1	Defibrillators (Defibrillator) 10/2020
1	Stents 07/2020
1	Critical Care (Surgical Intensive Care) 05/2019
1	Continuity of Patient Care 01/2016
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 11/2015
1	Patient Readmission 10/2015
1	Adjuvant Chemotherapy 10/2012